• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leishmaniasis, Visceral

Leishmaniasis, Visceral - 19 Studies Found

Completed : An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
: Visceral Leishmaniasis
: 2011-01-21
: Drug: Paromomycin sulfate Paromomycin IM Injection, 11 mg/kg as the base, intramuscular, once a day on 2
Completed : A Community Trial for Visceral Leishmaniasis (VL)
: Visceral Leishmaniasis
: 2010-02-14
:
  • Drug: Albendazole, Iron, Zinc and Vitamin A

Completed : Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
: Primary Visceral Leishmaniasis
: 2010-02-10
:
  • Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate

Completed : Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
:
  • Visceral Leishmaniasis
  • Kala Azar : 2006-04-25
    : Device: Long Lasting Impregnated Nets (LLIN) Distribution of LLIN in selected clusters
Completed : Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
: Visceral Leishmaniasis
: 2005-09-13
:
  • Drug: Paromomycin sulfate
  • Drug: Amphoteric

Completed : Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
: Visceral Leishmaniasis
: 2015-04-20
: Drug: Miltefosine
Not yet recruiting : Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
: Visceral Leishmaniasis
: 2017-04-21
:
  • Drug: Miltefosine Miltefosine

Completed : Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
: Visceral Leishmaniasis
: 2008-06-11
:
  • Drug: Amphotericin B Deoxycholate

Completed : A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
: Post-kala-azar Dermal Leishmaniasis
: 2013-10-23
: Drug: Mitefosine Tablet Miltefosine 100 mg in two devided doses for 12 weeks
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.